Endometriosis: bright future for a cloudy past?

Nothnick WB; Warren B. Nothnick

doi:10.1126/scitranslmed.aaa5075

Endometriosis: bright future for a cloudy past?

Nothnick WB, Warren B. Nothnick

Science translational medicine · 2015 · vol. 7(271) , pp. 271fs2 · doi:10.1126/scitranslmed.aaa5075 · PMID:25609165 · W2161714311

Review OA: closed CC0 ⤵ 2 in-corpus citations

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

New estrogen receptor ligands prevent endometriotic implant survival without affecting reproductive cycles in a mouse model, offering potential new treatment strategies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

New estrogen receptor ligands arrest endometriotic implant survival but spare reproductive cycles in a mouse model of endometriosis, thus forging a path to new treatment options (Zhao et al., this issue).

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Animals Animals Disease Models, Animal Disease Models, Animal Endometriosis Endometriosis Endometriosis Endometriosis Estrogens Estrogens Estrogens Female Female

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (11)

Aromatase inhibitors for the treatment of endometriosis via openalex
Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications via openalex
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis via openalex
Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study via openalex
Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis? via openalex
Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis? via openalex
Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation via openalex
Treating endometriosis as an autoimmune disease via openalex
W2093303434 via openalex
W2022779434 via openalex

Cited by (2)

Source provenance

europepmc: last seen: 2026-10-14T06:08:39.101224+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-10-08T21:14:54.911568+00:00
unpaywall: last seen: 2026-10-14T06:23:58.021457+00:00

License: CC0 · commercial use OK

[1] Aromatase inhibitors for the treatment of endometriosis via openalex

[2] Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications via openalex

[3] Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis via openalex

[4] Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study via openalex

[5] Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex

[6] Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis? via openalex

[7] Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis? via openalex

[8] Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation via openalex

[9] Treating endometriosis as an autoimmune disease via openalex

[10] W2093303434 via openalex

[11] W2022779434 via openalex